Analyst Consensus ?
ConsensusHold8 ratings
Bullish450.0%
Neutral337.5%
Bearish112.5%
Prudential plc · PUK · FY2024 Q4 · Calendar Q1 2025
Prudential targets 2025 growth as capital generation inflects
The supplied analysis supports a constructive but conditional view: strong 2024 new business and earnings growth, agency expansion, repricing and cost control underpin management’s raised 2025 targets. The thesis depends on converting operating free-surplus growth into dividends while containing regulatory, margin and execution risks.
Reported Before market openNYSEFinancial Services
$30.78B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus —
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus —
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-1.0%
Event window
SPY move
+1.1%
Same window
Abnormal move
-2.1%
Stock minus SPY
Volume
1.3×
Versus trailing sessions
Subsequent drift
+1.0%
Up to 20 sessions
PUKSPY benchmark
Ask FN2 about PUK FY2024 Q4
Transcript, numbers and history already loaded
What drove PUK's -1.0% move after FY2024 Q4 earnings?What changed in PUK's guidance and outlook in FY2024 Q4?Give me the bull and bear case for PUK after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management raised its outlook for 2025, framing the year as an operating free-surplus and dividend-growth inflection point. New information also included an HCL-backed Indian health-insurance joint venture and a potential Indian asset-management listing.
Guidance delta
Raised: management targets more than 10% growth in 2025 new business profit, operating earnings per share and dividends.
Key takeaways
- 2024 results exceeded guidance, with 11% new business profit growth and 8% adjusted operating profit per share growth.
- Management identified 2025 as an inflection year for operating free-surplus generation and dividend growth.
- Agency expansion, health and protection repricing, asset-management growth and cost containment are the main operating levers.
Management priorities
- Expand and activate the agency channel, targeting 80,000–90,000 active agents by 2026.
- Complete the Indian health joint venture with HCL Group and build it organically.
- Continue buybacks and dividend increases while pursuing growth across Asian and African markets.
Follow PUK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$24.45Current
$39.3Low
$39.3Average
$39.3High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Buy | Maintain | Feb 14, 2022 |
| HSBC | Buy | Hold | Upgrade | Mar 23, 2021 |
| Macquarie | Outperform | Outperform | Maintain | Oct 3, 2019 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 10, 2018 |
| JP Morgan | Neutral | Underweight | Upgrade | Mar 17, 2017 |
| Societe Generale | Sell | Hold | Downgrade | Oct 13, 2016 |
| Jefferies | Hold | Buy | Downgrade | Jul 20, 2015 |
| Charles Stanley | Buy | Accumulate | Maintain | Jun 10, 2015 |
Named analyst price targets
Upside is calculated against the persisted current price $24.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Berenberg Bank | Michael Huttner | $39.3 | $27.29 | +60.7% | Sep 3, 2026 |
Track every rating change on PUK the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPrudential plc, operating through its various subsidiaries, delivers a diverse array of financial solutions to individuals across Asia and Africa, encompassing life and health coverage, retirement planning, and comprehensive asset management services. Its product portfolio includes extensive health and protection plans, along with various savings instruments such as participating, unit-linked, and conventional policies.…
Historical context
All PUK earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FDS FactSet Research Systems Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.9% | +3.8% | FactSet reports record FY26 results as AI and MCP adoption accelerate |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the PUK recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-03-05T00:04:46.926786+00:00
- Polygon adjusted daily market bars · 2026-10-02T12:16:10.095239+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-02T12:16:10.092610+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-02. For educational purposes only; not investment advice.